BridgeMD
New treatment option for Idiopathic Toe Walking
Official title The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children
ClinicalTrials.gov ID: NCT07090057
What this study is testing
- What it's testing
- Tight ankle muscles can produce ankle equinus (limited ability to pull the foot upward) and occur often in children, significantly impacting their ability to walk. If not treated, children with ankle equinus frequently experience reduced function and long-term foot problems, such as pain.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 17
You may be able to join if
- (All of the following criteria must be met):
- Ability to provided informed consent/assent in English.
- Pediatric patients (4-17 years) who have consented for surgery for the management of equinus contracture \ (either TA lengthening or GN recession) at...
- Known underlying diagnosis of any of the following: idiopathic toe walking, cerebral palsy, hereditary spastic paraparesis, traumatic brain injury...
- Ability to maintain hindfoot and midfoot neutral during assessment
You likely can't join if
- (Any one or more of the following):
- Unable to provide informed consent/assent in English.
- Previous surgery for equinus
- Limb deficiency on affected side
- Knee flexion contracture of greater than 5°
- Surgical intervention of the lower extremities below the affected knee in the last twelve months
See the full eligibility criteria
- (All of the following criteria must be met):
- Ability to provided informed consent/assent in English.
- Pediatric patients (4-17 years) who have consented for surgery for the management of equinus contracture \ (either TA lengthening or GN recession) at the Stollery Children's Hospital
- Known underlying diagnosis of any of the following: idiopathic toe walking, cerebral palsy, hereditary spastic paraparesis, traumatic brain injury, spinal cord injury/tethering, hereditary sensory-motor neuropathy...
- Ability to maintain hindfoot and midfoot neutral during assessment
- Passive plantarflexion on affected side greater than 20° and greater than degree of equinus contracture.
- Note: may be isolated or in conjunction with other orthopaedic procedures; in bilateral ankle equinus procedures, data will be collected bilaterally, but included as a single participant (i.e., single randomization).
- (Any one or more of the following):
- Unable to provide informed consent/assent in English.
- Previous surgery for equinus
- Limb deficiency on affected side
- Knee flexion contracture of greater than 5°
- Surgical intervention of the lower extremities below the affected knee in the last twelve months
- BoNTA injections below the affected knee within the last six months
- Known or suspected arthrofibrosis.
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.